← Back to Patent Explorer
US4556658A Expired / Lapsed US ⏱️ 0.0 years remaining

7-Amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acids and antibacterial agents containing these compounds

Assignee: Bayer AG
•
Filing: 1984-04-24
•
Granted: 1985-12-03
•
Expires: 2004-04-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to 7-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acids, processes for their preparation and compositions containing them as antibacterial agents. Also included in the invention are methods for treating bacterial infection using the compounds and compositions of the invention.

Inventors

  • 👤 Klaus Grohe
  • 👤 Uwe Petersen
  • 👤 Hans-Joachim Zeiler
  • 👤 Karl G. Metzger

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 02:35
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D215/00; C07D215/02; C07D215/16; C07D215/48; C07D215/54; C07D215/56; A; A61; A61P; A61P31/00; A61P31/04; C07D401/04; C07D413/00; C07D413/02; C07D413/04

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 426 words
A 7-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-quinolinecarboxylic acid of the formula (I) ##STR33## in which R 1 and R 2 are identical or different and represent a C 1 -C 4 -alkyl radical which is optionally substituted by a hydroxyl, amino, methylamino or dimethylamino group, and R 1 and R 2 , together with the nitrogen atom to which they are bonded, furthermore form a 5-membered or 6-membered heterocyclic ring, which can additionally have, as a ring member, the atoms or groups --O--, --S--, --SO--, --SO 2 -- or >N-R 3 and which is optionally monosubstituted, disubstituted or trisubstituted at the carbon atoms by C 1 -C 4 -alkyl, hydroxyl, alkoxy having 1-3 carbon atoms, amino, methylamino or ethylamino, and each carbon atom carries no more than one substituent, and R 3 represents hydrogen, a branched or straight-chain alkyl, alkenyl or alkinyl group which has 1 to 6 carbon atoms and is optionally substituted by a hydroxyl, trifluoromethylmercapto, alkoxy, alkylmercapto, alkylamino or dialkylamino group having 1 to 3 carbon atoms per alkyl radical, the cyano group or the alkoxycarbonyl group having 1 to 4 carbon atoms in the alcohol part, or represents the benzyloxycarbonyl group, a phenylalkyl group which has up to 4 carbon atoms in the aliphatic part and is optionally substituted in the phenyl radical by nitro or amino, a phenyl radical which is optionally monosubstituted or disubstituted by hydroxyl, methoxy, chlorine or fluorine, a phenylacyl radical which is optionally monosubstituted or disubstituted by hydroxyl, methoxy, chlorine and fluorine, an oxoalkyl radical having up to 6 carbon atoms and a cycloalkyl-alkyl radical having up to 6 carbon atoms in the cyclic part and up to 3 carbon atoms in the acyclic part, and furthermore denotes a radical COR 4 , CN or SO 2 R 5 , wherein R 4 represents hydrogen or straight-chain or branched alkyl which has 1 to 4 C atoms and is optionally substituted by 1 or 2 substituents selected from amino, alkoxycarbonyl having 1 to 3 carbon atoms in the alkyl part, carboxyl, alkoxy having 1 to 3 carbon atoms and trifluoromethylthio, or represents phenyl which is optionally substituted by chlorine, hydroxyl, amino or carboxyl, or represents alkoxy having 1 to 4 C atoms, alkylthio having 1 or 2 C atoms, benzyloxy or amino, or represents alkylamino which has 1 to 5 C atoms and is optionally substituted by alkoxycarbonyl having 1 to 3 C atoms in the alkyl part or carboxyl, and R 5 represents straight-chain or branched alkyl having 1 to 3 C atoms, phenyl or methylphenyl, and its pharmaceutically useful salts.
Claim 2
Dependent Claim 426 words
A 7-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-quinolinecarboxylic acid of the formula (I) ##STR33## in which R 1 and R 2 are identical or different and represent a C 1 -C 4 -alkyl radical which is optionally substituted by a hydroxyl, amino, methylamino or dimethylamino group, and R 1 and R 2 , together with the nitrogen atom to which they are bonded, furthermore form a 5-membered or 6-membered heterocyclic ring, which can additionally have, as a ring member, the atoms or groups --O--, --S--, --SO--, --SO 2 -- or >N-R 3 and which is optionally monosubstituted, disubstituted or trisubstituted at the carbon atoms by C 1 -C 4 -alkyl, hydroxyl, alkoxy having 1-3 carbon atoms, amino, methylamino or ethylamino, and each carbon atom carries no more than one substituent, and R 3 represents hydrogen, a branched or straight-chain alkyl, alkenyl or alkinyl group which has 1 to 6 carbon atoms and is optionally substituted by a hydroxyl, trifluoromethylmercapto, alkoxy, alkylmercapto, alkylamino or dialkylamino group having 1 to 3 carbon atoms per alkyl radical, the cyano group or the alkoxycarbonyl group having 1 to 4 carbon atoms in the alcohol part, or represents the benzyloxycarbonyl group, a phenylalkyl group which has up to 4 carbon atoms in the aliphatic part and is optionally substituted in the phenyl radical by nitro or amino, a phenyl radical which is optionally monosubstituted or disubstituted by hydroxyl, methoxy, chlorine or fluorine, a phenylacyl radical which is optionally monosubstituted or disubstituted by hydroxyl, methoxy, chlorine and fluorine, an oxoalkyl radical having up to 6 carbon atoms and a cycloalkyl-alkyl radical having up to 6 carbon atoms in the cyclic part and up to 3 carbon atoms in the acyclic part, and furthermore denotes a radical COR 4 , CN or SO 2 R 5 , wherein R 4 represents hydrogen or straight-chain or branched alkyl which has 1 to 4 C atoms and is optionally substituted by 1 or 2 substituents selected from amino, alkoxycarbonyl having 1 to 3 carbon atoms in the alkyl part, carboxyl, alkoxy having 1 to 3 carbon atoms and trifluoromethylthio, or represents phenyl which is optionally substituted by chlorine, hydroxyl, amino or carboxyl, or represents alkoxy having 1 to 4 C atoms, alkylthio having 1 or 2 C atoms, benzyloxy or amino, or represents alkylamino which has 1 to 5 C atoms and is optionally substituted by alkoxycarbonyl having 1 to 3 C atoms in the alkyl part or carboxyl, and R 5 represents straight-chain or branched alkyl having 1 to 3 C atoms, phenyl or methylphenyl, and its pharmaceutically useful salts.
Claim 3
Dependent Claim 352 words
A 7-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-quinolinecarboxylic acid of claim 1 of the formula (I) ##STR34## in which R 1 and R 2 are identical or different and represent a C 1 -C 3 -alkyl radical which is optionally substituted by a hydroxyl or amino group, and R 1 and R 2 , together with the nitrogen atom to which they are bonded, form a 5-membered or 6-membered heterocyclic ring which can additionally contain, as a ring member, the atoms or groups --O--, --S--, --SO 2 -- or >N-R 3 and can be optionally monosubstituted or disubstituted at the carbon atoms by C 1 -C3-alkyl, hydroxyl, amino or methylamino, and each carbon atom can carry only one substituent, and R 3 represents hydrogen or a branched or straight-chain alkyl, alkenyl or alkinyl group which has 1 to 4 carbon atoms and can be optionally substituted by a hydroxyl, trifluoromethylmercapto, alkoxy or alkylmercapto group having 1 to 2 carbon atoms per alkyl radical, the cyano group or the alkoxycarbonyl group having 1 to 3 carbon atoms in the alcohol part, or represents the benzyloxycarbonyl group, a phenylalkyl group which has up to 2 carbon atoms in the aliphatic part and is optionally substitued in the phenyl radical by nitro or amino, or represents a phenacyl radical, an oxoalkyl radical having up to 5 carbon atoms and a cycloalkyl-alkyl radical having up to 6 carbon atoms in the cyclic part and up to 2 carbon atoms in the acyclic part, and furthermore denotes a radical COR 4 , CN or SO 2 R 5 , wherein R 4 denotes hydrogen or straight-chain or branched alkyl which has 1 to 3 C atoms and is optionally substituted by 1 or 2 substituents selected from the group consisting of amino, methoxycarbonyl, carboxyl, alkoxy having 1 or 2 carbon atoms or trifluoromethylthio, or denotes phenyl which is optionally substituted by chlorine or hydroxyl, or denotes alkoxy or alkylamino which has 1 to 5 C atoms and is optionally substituted by alkoxycarbonyl having 1 or 2 C atoms in the alkyl part or carboxyl, and R 5 denotes methyl, ethyl, phenyl or methylphenyl.
Claim 4
Dependent Claim 236 words
A 7-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-quinolinecarboxylic acid of claim 1 of the formula (I) ##STR35## in which R 1 and R 2 can be identical or different and represent a C 1 -C 2 -alkyl radical which is optionally substituted by a hydroxyl group, and R 1 and R 2 , together with the nitrogen atom to which they are bonded, furthermore can form a 6-membered heterocyclic ring which can additionally contain, as a ring member, the group N-R 3 and can be optionally monosubstituted or disubstituted at the carbon atoms by C 1 -C 2 -alkyl or hydroxyl, and each carbon atom can carry only one substituent, and R 3 represents hydrogen or a branched or straight-chain alkyl, alkenyl or alkinyl group which has 1 to 3 carbon atoms and can be optionally substituted by a hydroxyl group or the alkoxycarbonyl group having 1 or 2 carbon atoms in the alcohol part, or represents a benzyl group which is optionally substituted in the phenyl radical by amino, or represents a phenacyl radical, an oxoalkyl radical having up to 4 carbon atoms and a cyclopropylmethyl radical, and furthermore denotes a radical COR 4 or SO 2 R 5 , wherein R 4 denotes hydrogen, alkyl which has 1 or 2 C atoms and is optionally substituted by a substituent selected from amino and carboxyl, or denotes alkoxy having 1 or 2 C atoms or benzyloxy, and R 5 denotes methyl.
Claim 5
Dependent Claim 9 words
A compound of claim 1 which is 1-cyclopropyl-6,8-difluoro-7-(piperazin-1-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.
Claim 6
Dependent Claim 9 words
A compound of claim 1 which is 1-cyclopropyl-6,8-difluoro-7-(4-methylpiperazin-1-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.
Claim 7
Dependent Claim 9 words
A compound of claim 1 which is 1-cyclopropyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-1,4-dihydro-4-oxoquinoline-carboxylic acid.
Claim 8
Dependent Claim 9 words
A compound of claim 1 which is 1-cyclopropyl-6,8-difluoro-7-(4-ethylpiperazin-1-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.
Claim 9
Dependent Claim 9 words
A compound of claim 1 which is 1-cyclopropyl-6,8-difluoro-7-[4-(3-oxobutyl)-piperazin-1-yl]-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.
Claim 10
Dependent Claim 9 words
A compound of claim 1 which is 1-cyclopropyl-6,8-difluoro-7-(pyrrolidin-1-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.
Claim 11
Dependent Claim 25 words
A pharmaceutical composition containing as an active ingredient an antibacterially effective amount of a compound of claim 1 in admixture with an inert pharmaceutical carrier.
Claim 12
Dependent Claim 30 words
A pharmaceutical composition containing as an active ingredient an antibacterially effective amount of a compound of claim 1 in the form of a sterile or physiologically effective isotonic aqueous solution.
Claim 13
Dependent Claim 17 words
A composition of claim 10 containing from 0.5 to 90% by weight of the said active ingredient.
Claim 14
Dependent Claim 22 words
A pharmaceutical in dosage unit form comprising an antibacterially effective amount of a compound of claim 1 and an inert pharmaceutical carrier.
Claim 15
Dependent Claim 16 words
A medicament of claim 13 in the form of tablets, pills, dragees, capsules, ampoules or suppositories.
Claim 16
Dependent Claim 40 words
A method of combatting bacterial infection in warm-blooded animals which comprises administering to said animals an antibacterially effective amount of an active compound of claim 1 either alone, in admixture with a diluent or in the form of a medicament.
Claim 17
Dependent Claim 27 words
A method of claim 1 in which the active compound is administered in an amount of about 0.05 to about 100 mg/kg of body weight per day.
Claim 18
Dependent Claim 27 words
A method of claim 16 in which the active compound is administered in an amount of about 0.1 to about 10 mg/kg of body weight per day.

References Cited (Backward Citations)

US3149104A Cited
DE2939786A1 Cited
GB2085875A Cited
DE3306772A1 Cited
DE3306771A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-12-02 1989-06-03 1989-12-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-12-02 1993-06-03 1993-12-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-12-02 1997-06-03 1997-12-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag